Cytopia adds and subtracts
Thursday, 10 July, 2008
Cytopia [ASX: CYT] has appointed Anadys Pharmaceuticals founder Dr Devron Averett as the company's new scientific advisor.
Averett has a Ph.D in microbiology and immunology and is an inventor of 17 current and nine pending US patents. He has had previous roles with Glaxo Wellcome and Burroughs Wellcome.
His work contributed to the discovery of a number of oncology and anti-viral drug candidates, including Zeffix, Emtriva and Ziagen.
The Melbourne-headquartered company has closed its New York office, losing business and corporate development VP Dr Shreefal Mehta, and will concentrate its US operations on California.
It has also appointed financial specialist Richard Haiduck as chief business advisor.
SEQ koala population carries immunity to retrovirus
Koalas from a population north of the Brisbane River appear to have evolved a unique genomic...
RSV immunisation program for babies slashes hospital stays
An Australian-first study has demonstrated the effectiveness of immunisation against respiratory...
A targeted treatment option for psoriasis
New research from MedUni Vienna paves the way for the development of a therapy that not only...